ISSN: 1873-4316 (Online)
ISSN: 1389-2010 (Print)
Volume 15, 12 Issues, 2014
Download PDF Flyer
SCImago Journal Ranking
"Current Pharmaceutical Biotechnology presents the latest developments in the area of biotechnology. This is strongly recommended."
|Forthcoming Special Issue(s)|
ADVANCES IN PHARMACEUTICAL BIOTECHNOLOGY
Guest Editor(s): Ana Catarina Silva, Maria Helena Amaral, Ana Catarina Silva, Carla Martins Lopes, José Manuel Sousa Lobo
Tentative Publication Date: April, 2015
Submit Abstract via Email Download Description
Recently, I had a nice experience through the publication of a paper in the Current Pharmaceutical Biotechnology. I would like to take this opportunity to acknowledge the Editor in-chief of the Current pharmaceutical Biotechnology, and especially Publication Manager Ms. Sumaiya Azhar for her outstanding professionalism, kindness and availability in the management of the peer review process and the editing the manuscript. I really appreciate this nice moment.|
Dr. Jin Bo Su
Has contributed: Kinins and Cardiovascular Diseases
Current Pharmaceutical Biotechnology
Small Molecule Inhibitors Limit Endothelial Cell Invasion by Staphylococcus aureus
; Pp: 727 - 737
Diana Cordero, Christopher R. Fullenkamp, Rachel R. Pelly, Katie M. Reed, Lindy M. Caffo, Ashley N. Zahrt, Micaleah Newman, Sarah Komanapalli, Evan M. Niemeier, Derron L. Bishop, Heather A. Bruns, Mark K. Haynes, Larry A. Sklar, Robert E. Sammelson and Susan A. McDowell
View Abstract Purchase Online Rights and Permissions
2014 Nobel Prize in Chemistry
Drs. Eric Betzig, Stefan W. Hell and William E. Moerner share the 2014 chemistry Nobel for the development of super-resolved fluorescence microscopy.
“The Royal Swedish Academy of Sciences has decided to award the 2014 Nobel Prize in Chemistry to Dr. Eric Betzig at Howard Hughes Medical Institute, Ashburn, U.S.A.; Professor Stefan Hell at Max Planck Institute for Biophysical Chemistry, Göttingen, and the German Cancer Research Center, Heidelberg, Germany; and Professor William Moerner at Stanford University, Stanford, U.S.A., for the development of super-resolved fluorescence microscopy.”
Much research effort was needed to realize that single-cell and single-molecule based approaches directly affect improvements in human health. However, many of these laboratory technologies are not available in a cheap and easy version. Single-molecule based fluorescence imaging and detection have the advantages of a small volume platform, digital analysis, elimination of processing steps, real-time measurements and automation of sample preparation. In 2015, Current Pharmaceutical Biotechnology will continue in this direction with quality papers that can be expected to trigger further investigations.
Drs. Eric Betzig and William E. Moerner also developed methods and biotechniques which have enabled the study of single molecules in ongoing chemical reactions in living cells. Because now it is possible to see individual macromolecules moving about in a living cell, we can study chemistry at a single-molecule level and in real life. And this is very important to chemistry because chemistry has traditionally been about studying a large number of molecules and the effect that they have. The journal Current Pharmaceutical Biotechnology has published on this research and has been at the forefront for over more than one decade. Curr. Pharm. Biotechnol. has published thematic issues, original research and review articles about the entirely new possibilities for chemistry and for biochemistry by eminent scientists from around the world, some examples: